FGF-16 is a target for adrenergic stimulation through NF-B activation in postnatal cardiac cells and adult mouse heart

Cardiovascular Research

Volumn 87, Issue 1, 2010, Pages 102-110

  Sofronescu, Alina G ^a   Detillieux, Karen A ^a   Cattini, Peter A ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

FGF 16; Gene regulation; Isoproterenol; Mouse and human heart; Nuclear factor kappaB

Indexed keywords

FIBROBLAST GROWTH FACTOR 16; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPRENALINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; FGF16 PROTEIN, HUMAN; FGF16 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR; MESSENGER RNA;

ANIMAL CELL; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSFECTION; HEART MUSCLE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TATA BOX; ADULT; AGED; ANIMAL; BINDING SITE; CELL CULTURE; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MOLECULAR GENETICS; NEWBORN; NUCLEOTIDE SEQUENCE; RAT; TIME; YOUNG ADULT;

ADRENERGIC BETA-AGONISTS; ADULT; AGED; ANIMALS; ANIMALS, NEWBORN; BASE SEQUENCE; BINDING SITES; CELLS, CULTURED; CONSERVED SEQUENCE; FEMALE; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; HUMANS; ISOPROTERENOL; MALE; MICE; MOLECULAR SEQUENCE DATA; MYOCYTES, CARDIAC; NF-KAPPA B; PROMOTER REGIONS, GENETIC; RATS; RNA, MESSENGER; TIME FACTORS; TRANSFECTION; YOUNG ADULT;

EID: 77955161546     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq025     Document Type: Article

References (24)

1. Lavine KJ, Yu K, White AC, Zhang X, Smith C, Partanen J et al. Endocardial and epi-cardial derived FGF signals regulate myocardial proliferation and differentiation in vivo. Dev Cell 2005;8:85-95.
2. Lu SY, Sheikh F, Sheppard PC, Fresnoza A, Duckworth ML, Detillieux KA et al. FGF-16 is required for embryonic heart development. Biochem Biophys Res Commun 2008;373:270-274.
3. Hotta Y, Sasaki S, Konishi M, Kinoshita H, Kuwahara K, Nakao K et al. FGF-16 is required for cardiomyocyte proliferation in the mouse embryonic heart. Dev Dyn 2008;237:2947-2954.
4. Miyake A, Konishi M, Martin FH, Hernday NA, Ozaki K, Yamamoto S et al. Structure and expression of a novel member, FGF-16, on the fibroblast growth factor family. Biochem Biophys Res Commun 1998;243:148-152.
5. Lu SY, Sontag DP, Detillieux KA, Cattini PA. FGF-16 is released from neonatal cardiac myocytes and alters growth-related signaling: a possible role in postnatal development. Am J Physiol Cell Physiol 2008;294:C1242-C1249.
6. Sofronescu AG, Jin Y, Cattini PA. A myocyte enhancer factor 2 (MEF2) site located in a hypersensitive region of the FGF-16 gene locus is required for preferential promoter activity in neonatal cardiac myocytes. DNA Cell Biol 2008;27:173-182.
7. Shaw J, Zhang T, Rzeszutek M, Yurkova N, Baetz D, Davie JR et al. Transcriptional silencing of the death gene BNIP3 by cooperative action of NF-kappaB and histone deacetylase 1 in ventricular myocytes. Circ Res 2006;99:1347-1354.
8. Haudek SB, Bryant DD, Giroir BP. Differential regulation of myocardial NF kappa B following acute or chronic TNF-alpha exposure. J Mol Cell Cardiol 2001;33: 1263-1271.
9. Hall G, Hasday JD, Rogers TB. Regulating the regulator: NF-kappaB signaling in heart. J Mol Cell Cardiol 2006;41:580-591.
10. Ashburner BP, Westerheide SD, Baldwin AS Jr. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 2001;21:7065-7077.
11. Valen G, Yan ZQ, Hansson GK. Nuclear factor kappa-B and the heart. J Am Coll Cardiol 2001;38:307-314.
12. Chandrasekar B, Marelli-Berg FM, Tone M, Bysani S, Prabhu SD, Murray DR. Beta-adrenergic stimulation induces interleukin-18 expression via beta2-AR, PI3K, Akt, IKK, and NF-kappaB. Biochem Biophys Res Commun 2004;319:304-311.
13. Condorelli G, Morisco C, Latronico MV, Claudio PP, Dent P, Tsichlis P et al. TNF-alpha signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF-alpha receptor. FASEB J 2002;16:1732-1737.
14. Doble BW, Chen Y, Bosc DG, Litchfield DW, Kardami E. Fibroblast growth factor-2 decreases metabolic coupling and stimulates phosphorylation as well as masking of connexin43 epitopes in cardiac myocytes. Circ Res 1996;79:647-658.
15. Jimenez SK, Sheikh F, Jin Y, Detillieux KA, Dhaliwal J, Kardami E et al. Transcriptional regulation of FGF-2 gene expression in cardiac myocytes. Cardiovasc Res 2004;62: 548-557.
16. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 1992;175: 1181-1194.
17. Catley MC, Sukkar MB, Chung KF, Jaffee B, Liao SM, Coyle AJ et al. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle. Mol Pharmacol 2006;70:697-705.
18. Itoh N, Ornitz DM. Evolution of the Fgf and Fgfr gene families. Trends Genet 2004;20: 563-569.
19. Antoine M, Wirz W, Tag CG, Gressner AM, Wycislo M, Müller R et al. Fibroblast growth factor 16 and 18 are expressed in human cardiovascular tissues and induce on endothelial cells migration but not proliferation. Biochem Biophys Res Commun 2006;346:224-233.
20. Freund C, Schmidt-Ullrich R, Baurand A, Dunger S, Schneider W, Loser P et al. Requirement of nuclear factor-kappaB in angiotensin II-and isoproterenol-induced cardiac hypertrophy in vivo. Circulation 2005;111:2319-2325.
21. Takemoto Y, Yoshiyama M, Takeuchi K, Omura T, Komatsu R, Izumi Y et al. Increased JNK, AP-1 and NF-kappa B DNA binding activities in isoproterenol-induced cardiac remodeling. J Mol Cell Cardiol 1999;31:2017-2030.
22. Rodriguez MS, Wright J, Thompson J, Thomas D, Baleux F, Virelizier JL et al. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo. Oncogene 1996;12:2425-2435.
23. Minatoya H, Lands AM, Portmann GA. Absorption and elimination profile of isopro-terenol in anesthetized dogs. J Pharm Sci 1965;54:968-972.
24. Zhong H, May MJ, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 2002;9:625-636.